Misiewicz M - Search Results

1

High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.

Mikulski D, Nowicki M, Dróźdż I, Misiewicz M, Kościelny KP, Okoński K, Krawiec K, Perdas E, Wierzbowska A, Fendler W. Mikulski D, et al. Among authors: misiewicz m. Front Oncol. 2023 Sep 27;13:1250355. doi: 10.3389/fonc.2023.1250355. eCollection 2023. Front Oncol. 2023. PMID: 37829335 Free PMC article.

2

miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment.

Nowicki M, Szemraj J, Wierzbowska A, Misiewicz M, Małachowski R, Pluta A, Grzybowska-Izydorczyk O, Robak T, Szmigielska-Kapłon A. Nowicki M, et al. Among authors: misiewicz m. Eur J Haematol. 2018 May;100(5):426-435. doi: 10.1111/ejh.13036. Epub 2018 Feb 27. Eur J Haematol. 2018. PMID: 29380440

3

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib.

Robak P, Węgłowska E, Dróżdż I, Mikulski D, Jarych D, Ferlińska M, Wawrzyniak E, Misiewicz M, Smolewski P, Fendler W, Szemraj J, Robak T. Robak P, et al. Among authors: misiewicz m. Mediators Inflamm. 2020 Jun 6;2020:1835836. doi: 10.1155/2020/1835836. eCollection 2020. Mediators Inflamm. 2020. PMID: 32587468 Free PMC article.

4

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients.

Robak P, Dróżdż I, Jarych D, Mikulski D, Węgłowska E, Siemieniuk-Ryś M, Misiewicz M, Stawiski K, Fendler W, Szemraj J, Smolewski P, Robak T. Robak P, et al. Among authors: misiewicz m. Cancers (Basel). 2020 Sep 9;12(9):2569. doi: 10.3390/cancers12092569. Cancers (Basel). 2020. PMID: 32916955 Free PMC article.

5

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib.

Robak P, Jarych D, Mikulski D, Dróżdż I, Węgłowska E, Kotkowska A, Misiewicz M, Smolewski P, Stawiski K, Fendler W, Szemraj J, Robak T. Robak P, et al. Among authors: misiewicz m. Cancers (Basel). 2021 Feb 25;13(5):951. doi: 10.3390/cancers13050951. Cancers (Basel). 2021. PMID: 33668794 Free PMC article.

6

Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.

Robak P, Szemraj J, Mikulski D, Drozdz I, Juszczak K, Jarych D, Misiewicz M, Kościelny K, Fendler W, Robak T. Robak P, et al. Among authors: misiewicz m. J Clin Med. 2021 Oct 28;10(21):5028. doi: 10.3390/jcm10215028. J Clin Med. 2021. PMID: 34768548 Free PMC article.

7

Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.

Mikulski D, Robak P, Perdas E, Węgłowska E, Łosiewicz A, Dróżdż I, Jarych D, Misiewicz M, Szemraj J, Fendler W, Robak T. Mikulski D, et al. Among authors: misiewicz m. J Clin Med. 2021 Dec 26;11(1):112. doi: 10.3390/jcm11010112. J Clin Med. 2021. PMID: 35011853 Free PMC article.

8

The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.

Puła A, Robak P, Jarych D, Mikulski D, Misiewicz M, Drozdz I, Fendler W, Szemraj J, Robak T. Puła A, et al. Among authors: misiewicz m. Int J Mol Sci. 2023 Feb 2;24(3):2938. doi: 10.3390/ijms24032938. Int J Mol Sci. 2023. PMID: 36769265 Free PMC article.

9

Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study.

Puła A, Robak T, Dróżdż I, Stawiski K, Rycerz A, Misiewicz M, Robak P. Puła A, et al. Among authors: misiewicz m. Leuk Lymphoma. 2024 Feb;65(2):257-264. doi: 10.1080/10428194.2023.2278431. Epub 2024 Jan 24. Leuk Lymphoma. 2024. PMID: 37948578

10

A low thrombospondin-1 serum concentration is related to increased bacteremia risk in lymphoma patients treated with BeEAM/BEAM conditioning regimen and autologous stem cell transplantation.

Kościelny K, Mikulski D, Nowicki M, Wyka K, Misiewicz M, Perdas E, Wierzbowska A, Fendler W. Kościelny K, et al. Among authors: misiewicz m. Transpl Infect Dis. 2024 Feb;26(1):e14212. doi: 10.1111/tid.14212. Epub 2023 Dec 19. Transpl Infect Dis. 2024. PMID: 38112043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters